System and method for evaluating and comparing medical treatments
First Claim
Patent Images
1. A computer-implemented method for evaluating a drug, biologic or medical device in research and development, the method comprising:
- using a computerized processor for;
defining a maximum benefit numerical score representing total benefits of a drug, biologic or medical device based on clinical trial data;
defining a maximum risk numerical score representing total risks of the drug, biologic or medical device based on clinical trial data;
receiving identification of a plurality of model categories, wherein the model categories are selected from;
a plurality of medical efficacy and safety categories;
a plurality of value proposition categories; and
a plurality of market dynamics categories;
receiving scaled adjustment values associated with the identified model categories, wherein the scaled adjustment values represent importance of factor elements within a model category;
apportioning the maximum benefit numerical score among the identified model categories based on the scaled adjustment values associated with the model categories;
apportioning the maximum risk numerical score among the identified model categories based on the scaled adjustment values associated with the model categories;
receiving an identification of one or more factor elements defined within one or more of the model categories;
receiving a plurality of risk scores and benefit scores for the identified factor elements;
generating an overall numerical benefit score based on the aggregate of the benefit scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories;
generating an overall numerical risk score based on the aggregate of the risk scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories;
storing the overall numerical risk and overall numerical benefit scores for the drug, biologic or medical device as separate benefit and risk values in a computerized storage device; and
displaying the stored overall scores on one or more axes.
2 Assignments
0 Petitions
Accused Products
Abstract
An evaluative software tool to support the assessment of health care-related technologies during development to facilitate making critical decisions for an optimized research, development and commercialization plan is provided. The software tool includes the ability to measure, weight, and integrate the critical factors that come into play in the development of a risk/benefit profile of a technology relative to its competitors, benchmarked around clinical trial measures, in order to determine its development and commercialization success.
-
Citations
20 Claims
-
1. A computer-implemented method for evaluating a drug, biologic or medical device in research and development, the method comprising:
-
using a computerized processor for; defining a maximum benefit numerical score representing total benefits of a drug, biologic or medical device based on clinical trial data; defining a maximum risk numerical score representing total risks of the drug, biologic or medical device based on clinical trial data; receiving identification of a plurality of model categories, wherein the model categories are selected from; a plurality of medical efficacy and safety categories; a plurality of value proposition categories; and a plurality of market dynamics categories; receiving scaled adjustment values associated with the identified model categories, wherein the scaled adjustment values represent importance of factor elements within a model category; apportioning the maximum benefit numerical score among the identified model categories based on the scaled adjustment values associated with the model categories; apportioning the maximum risk numerical score among the identified model categories based on the scaled adjustment values associated with the model categories; receiving an identification of one or more factor elements defined within one or more of the model categories; receiving a plurality of risk scores and benefit scores for the identified factor elements; generating an overall numerical benefit score based on the aggregate of the benefit scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories; generating an overall numerical risk score based on the aggregate of the risk scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories; storing the overall numerical risk and overall numerical benefit scores for the drug, biologic or medical device as separate benefit and risk values in a computerized storage device; and displaying the stored overall scores on one or more axes. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
-
13. A computer-implemented method for evaluating a drug, biologic or medical device in research and development, the method comprising:
-
using a computerized processor for; defining a maximum benefit numerical score representing total benefits of a drug, biologic or medical device based on clinical trial data; defining a maximum risk numerical score representing total risks of the drug, biologic or medical device based on clinical trial data; receiving identification of a plurality of model categories, wherein the model categories are selected from; a plurality of medical efficacy and safety categories; a plurality of value proposition categories; and a plurality of market dynamics categories; apportioning the maximum benefit numerical score among the identified model categories; apportioning the maximum risk numerical score among the identified model categories; receiving an identification of one or more factor elements defined within one or more of the model categories; receiving a plurality of risk scores and benefit scores for the identified factor elements; receiving scaled adjustment values associated with the identified factor elements, wherein the scaled adjustment values represent the importance of factor elements within a model category; generating an overall numerical benefit score based on the aggregate of the benefit scores for the identified factor elements as adjusted by the scaled adjustment values associated with the identified factor elements; generating an overall numerical risk score based on the aggregate of the risk scores for the identified factor elements as adjusted by the scaled adjustment values associated with the identified factor elements; storing the overall numerical risk and overall numerical benefit scores for the drug, biologic or medical device as separate benefit and risk values in a computerized storage device; and displaying the stored overall scores on one or more axes. - View Dependent Claims (14, 15, 16)
-
-
17. A computer system, comprising:
-
an input device; an output device; a processor configured for; defining a maximum benefit numerical score representing total benefits of a drug, biologic or medical device based on clinical trial data; defining a maximum risk numerical score representing total risks of the drug, biologic or medical device based on clinical trial data; receiving identification of a plurality of model categories, wherein the model categories are selected from; a plurality of medical efficacy and safety categories; a plurality of value proposition categories; and a plurality of market dynamics categories; receiving scaled adjustment values associated with the identified model categories, wherein the scaled adjustment values represent importance of factor elements within a model category; apportioning the maximum benefit numerical score among the identified model categories based on the scaled adjustment values associated with the model categories; apportioning the maximum risk numerical score among the identified model categories based on the scaled adjustment values associated with the model categories; receiving an identification of one or more factor elements defined within one or more of the model categories; receiving a plurality of risk scores and benefit scores for the identified factor elements; generating an overall numerical benefit score based on the aggregate of the benefit scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories; generating an overall numerical risk score based on the aggregate of the risk scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories; storing the overall numerical risk and overall numerical benefit scores for the drug, biologic or medical device as separate benefit and risk values in a computerized storage device; and displaying the stored overall scores on one or more axes. - View Dependent Claims (18, 19, 20)
-
Specification